-
Mashup Score: 1Developing Standardized Metrics and Definitions for Foundational Models in Biomedicine - 5 month(s) ago
Enhancing Trust and Transparency in AI-Enabled Biomedical Innovations
Source: insights.phyusion.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
From Ancient Wisdom to Artificial Intelligence
Source: insights.phyusion.comCategories: General Medicine News, Hem/OncsTweet-
“Science is a journey from untested explanations to empirical evidence, a transition from seeking absolute certainty to embracing the power of doubt and skepticism” https://t.co/hcUpRJh3bh
-
-
Mashup Score: 0Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) - 6 month(s) ago
Advancing Gene Editing with Precision and Prudence
Source: insights.phyusion.comCategories: General Medicine News, Future of MedicineTweet-
CRISPR's precision in gene editing has propelled us into an era of rapid innovation. From the initial shockwaves of engineered CRISPR babies to the cusp FDA-approved therapies, the remarkable progress is the tip of the iceberg in a transformative journey. https://t.co/W1ZZML6cpn
-
-
Mashup Score: 0
An algorithmic musical exploration of physiological state transitions
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Physiological Harmony and Dissonance: The Confluence of Math, Music, and Medicine. An algorithmic musical exploration of physiological state transitions. https://t.co/NjXkTdZRVA
-
-
Mashup Score: 0FDA Releases Two Discussion Papers on AI/ML - 1 year(s) ago
The agency covers two parallel topics: AI/ML in drug/biologics development and manufacturing
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
FDA Releases Two Discussion Papers on AI/ML The agency covers two parallel topics: AI/ML in drug/biologics development and manufacturing [May 10, 2023] @SeanKhozin Phyusion https://t.co/8StZziNAFp #AI #ML
-
-
Mashup Score: 0FDA Releases Two Discussion Papers on AI/ML - 1 year(s) ago
The agency covers two parallel topics: AI/ML in drug/biologics development and manufacturing
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
A summary of FDA's discussion papers on the transformative role of #AI & #ML in drug development and manufacturing. FDA's stance is a welcomed step towards building consensus on these topics in the rapidly evolving age AI & ML in biomedicine and healthcare https://t.co/isZWOL4Npd
-
-
Mashup Score: 0Life in the Fast Lane: Navigating a New Era in FDA's Accelerated Approval Program in Oncology - 1 year(s) ago
The agency’s preference for randomized clinical trials over single arm studies can have major implications for clinical development programs and innovations in external controls and digital twins
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
From the inception of FDA’s accelerated approvals (AA) in 1992 to 2017, over 70% of oncology therapies approved under the program were based on single-arm trials. FDA’s new AA draft guidance strongly favors randomized controlled trials in this setting. https://t.co/nN01MNOgDk
-
-
Mashup Score: 0How Innovative Finance Can Drive Innovative Science: The Case for Research Backed Obligations and "Megafunds” - 1 year(s) ago
Roger M. Stein, PhD and Sean Khozin, MD, MPH
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Innovative finance can drive innovative science!💡 Excited to share a short piece co-written with Roger M. Stein discussing his work with Prof. Andrew Lo of MIT in developing novel financial engineering solutions to advance cancer drug development. https://t.co/K7zuuDW7NJ
-
-
Mashup Score: 0Regulatory Watch: US FDA Hematology-Oncology Approvals - 1 year(s) ago
A brief overview of FDA approvals from January 1 to March 27, 2023
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
FDA Heme-Onc approvals so far this year are quite interesting: first antibody-drug conjugate for HR+ breast cancer, BTK inhibitor for relapsed/refractory mantle cell lymphoma, & HER2 small molecule + trastuzumab for RAS wild-type HER2+ colorectal cancer https://t.co/JEiSxniJIx https://t.co/TABlnpEUiv
-
-
Mashup Score: 0February 2023, Part I - 1 year(s) ago
Tissue agnostic driven neoadjuvant treatment, molecular signatures of brain aging, serine/threonine kinome, AI prediction in gastric cancers, Kaposi sarcoma diagnosis, AI lung cancer risk prediction
Source: insights.phyusion.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Tissue agnostic #neoadjuvant therapy, molecular signatures of #brainaging, serine/threonine kinome, predicting #gastriccancer with #AI, improved #Kaposisarcoma diagnosis, & reducing #lungcancer risk with AI prediction https://t.co/yzMTjYHyBh
-
"Lately, we have been increasingly hearing claims of the development of foundational models in biomedicine. But the question is, are these models genuinely foundational in nature or are the claims mere marketing strategies?" https://t.co/PXdIbLyTxu https://t.co/VbrnrWTn8k